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Abstract
Introduction
Differences in risk for death from diseases and other causes among racial/ethnic groups likely contributed to the limited 
improvement in the state of health in the United States in the last few decades. The objective of this study was to identify causes of 
death that are the largest contributors to health disparities among racial/ethnic groups.
Methods
Using data from WONDER system, we measured the relative (age-adjusted mortality ratio [AAMR]) and absolute (difference in years 
of life lost [dYLL]) differences in mortality risk between the non-Hispanic white population and the black, Hispanic, American 
Indian/Alaska Native, and Asian/Pacific Islander populations for the 25 leading causes of death.
Results
Many causes contributed to disparities between non-Hispanic whites and blacks, led by assault (AAMR, 7.56; dYLL, 4.5 million). 
Malignant neoplasms were the second largest absolute contributor (dYLL, 3.8 million) to black–white disparities; we also found 
substantial relative and absolute differences for several cardiovascular diseases. Only assault, diabetes, and diseases of the liver 
contributed substantially to disparities between non-Hispanic whites and Hispanics (AAMR ≥ 1.65; dYLL ≥ 325,000). Many causes of 
death, led by assault (AAMR, 3.25; dYLL, 98,000), contributed to disparities between non-Hispanic whites and American 
Indians/Alaska Natives; Asian/Pacific Islanders did not have a higher risk than non-Hispanic whites for death from any disease.
Conclusion
Assault was a substantial contributor to disparities in mortality among non-Asian racial/ethnic minority populations. Research and 
intervention resources need to target diseases (such as diabetes and diseases of the liver) that affect certain racial/ethnic populations.
Introduction
A recent report underscored dramatic improvements in the state of health in the United States but also noted that improvements 
have not been as rapid as they have been in other wealthy nations (1). Differential risk in subpopulations (health disparities) is a likely 
contributor to this shortfall. Life expectancy differs among racial/ethnic groups; in 2006, life expectancy for whites was 78.5 years, 
lower than the life expectancy for Asians (86.6 y) or Hispanics (82.8 y) but higher than the life expectancy for blacks (73.4 y) or 
American Indians or Alaska Natives (74.2 y) (2). However, differences in life expectancy do not account for racial/ethnic differences 
in causes of death.
The Minority Health and Health Disparities Research and Education Act of 2000 requires the National Institutes of Health to study 
health disparities among racial/ethnic groups. However, the law does not provide guidance for allocating resources for research on 
specific diseases or racial/ethnic groups. One study noted a confounding of race and region, with different life expectancies for whites 
in Appalachia and whites in the Mississippi Valley, low-income rural whites in the northern plains and the Dakotas, and whites from 
other regions; and different life expectancies for southern low-income rural blacks, high-risk urban blacks, and other blacks (3). 
Because of limited funding to investigate disparities, resources should be allocated according to the impact of the disparity. Should 
this allocation be driven by data on relative differences or data on absolute differences? Suppose 2 diseases are competing for 
resources. The first disease demonstrates a large relative difference in mortality risk among racial/ethnic groups; however, the 
disease is rare, or the racial/ethnic group affected is small. The second disease demonstrates a small relative difference in mortality 
risk among racial/ethnic groups, but the disease is common, and the racial/ethnic group affected is large, so the disease and the 
disparity affect many people. There is value in addressing both large relative and large absolute differences in mortality risk. The 
objective of this study was to provide measures of relative and absolute differences in mortality risk for the 25 leading causes of death 
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in 5 racial/ethnic groups: American Indians and Alaska Natives (AIAN), Asians and Pacific Islanders (API), blacks, Hispanics, and 
non-Hispanic whites.
Methods
Data were retrieved from the Wide-Ranging Online Data for Epidemiologic Research (WONDER) system supported by the Centers 
for Disease Control and Prevention (4). In 1999, the WONDER system converted codes for cause of death to International 
Classification of Diseases, 10th Revision (ICD-10) codes; data are available for a 12-year period through 2010. For each ICD-10 
subchapter, we first retrieved data on the number of deaths and calculated the total number of person-years at risk by summing the 
population in each of the 12 study years. We then tabulated age-adjusted (to the 2000 US population) mortality rates for each 
racial/ethnic group (non-Hispanic white, black, Hispanic, American Indian/Alaska Native [AIAN], Asian/Pacific Islander [API]). 
Because the number of deaths was too small to provide stable estimates, our racial/ethnic classification excluded a small number of 
Hispanic AIAN, Hispanic API, and Hispanic blacks from the analyses (collectively 4,072,827 of 3,530,708,204 [0.1%] of the total 
person-years at risk).
The relative measure of disparity was the age-adjusted mortality ratio (AAMR), calculated as the age-adjusted mortality rate for the 
racial/ethnic minority group of interest divided by the age-adjusted mortality rate for non-Hispanic whites. The absolute measure of 
disparity was difference in years of life lost (dYLL), derived by first calculating the “excess” (or “deficit”) number of deaths in each age 
stratum (<1 y, 1–4 y, 5–9 y, 10–14 y, 15–19 y, 20–24 y, 25–34 y, 35–44 y, 45–54 y, 55–64 y, 65–74 y, 75–84, and ≥85 y) as the 
difference between the observed number of deaths and the expected number of deaths (population of racial/ethnic minority group × 
age stratum death rate for non-Hispanic whites) for the stratum. For each age stratum, the sum of the expected years of life was 
calculated from the non-Hispanic white life table (5), and the dYLL calculated as the sum of the years of life lost across the age strata. 
In our initial analysis, the top 25 causes of death included only 86% of the deaths for the black and Hispanic populations and 87% for 
the AIAN population; this raised the possibility that other diseases could be important in these populations. A post hoc analysis 
examined the next 25 leading causes of death. 
Results
Overall, the 25 leading causes of death caused 90% of all deaths (Table 1). Malignant neoplasms ranked first as cause of death among 
all racial/ethnic groups, according to age-adjusted mortality rates (Table 2).
For the black population, the largest AAMR (7.56) and largest dYLL (4.5 million) was for assault (Figure, Panel A, and Supplemental 
Table 1 in the Appendix). Because malignant neoplasm was a common cause of death, it contributed to the second largest dYLL 
(nearly 3.8 million) despite a small AAMR (1.22). Similarly, ischemic heart disease (AAMR, 1.19; dYLL, 2.7 million), other forms of 
heart disease (AAMR, 1.27; dYLL, 2.0 million), and cerebrovascular disease (AAMR, 1.44; dYLL, 2.0 million) had modest AAMRs but 
contributed to large dYLLs. In contrast, hypertensive diseases (AAMR, 2.99; dYLL, 2.3 million), diabetes (AAMR, 2.23; dYLL, 1.8 
million), renal failure (AAMR, 2.35; dYLL, 1.2 million), and other bacterial diseases (AAMR, 2.20; dYLL, 980,000) were less common 
causes of death, but their higher relative risk contributed to large dYLLs.
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Figure. Scatterplots of relative measure of disparities (age-adjusted mortality ratio [AAMR]) and absolute measures of disparities 
(difference in years of life lost [dYLL]) for each of 4 racial/ethnic minority groups compared with the non-Hispanic white population for 
the 25 leading causes of death in the United States, 1999–2010. Causes of death were categorized according to the International 
Classification of Diseases, 10  Revision. Scatterplot A is for non-Hispanic blacks; B for Hispanic whites; C for non-Hispanic 
Asians/Pacific Islanders; and D for non-Hispanic American Indians/Alaska Natives. Abbreviations for categories of causes of death 
were used to provide clearer plots. Abbreviations: Cancer, malignant neoplasms; IHD, ischemic heart disease; Other HD, other forms 
of heart disease; Stroke, cerebrovascular disorders; COPD, chronic lower respiratory diseases; Diabetes, diabetes mellitus; Other 
Nervous, other degenerative diseases of the nervous system; Other Accidents, other external causes of accidental injury; Mental 
Disorder, organic, including symptomatic, mental disorders; Influenza/Pneumonia, influenza or pneumonia; Hypertensive, 
hypertensive diseases; Transport, transport accidents; Renal, renal failure; Liver, diseases of the liver; Bacterial, other bacterial 
diseases; AAC, diseases of the arteries, arterioles or capillaries; Suicide, intentional self-harm; Intestines, other diseases of the 
intestines; Movement, extrapyramidal or movement disorders; Lung/External, lung diseases due to external agents; Assault, assault; 
Ill-Defined, ill-defined or unknown causes of mortality; Other Respiratory, other respiratory diseases principally affecting the 
interstitium; Metabolic, metabolic disorders; Urinary, other diseases of the urinary systems.
Blacks had a lower risk for death from several causes than did whites. Among those causes, the largest dYLL between blacks and 
whites was for intentional self-harm (AAMR, 0.41; dYLL = −1.2 million). Blacks had a lower relative risk for death from 
extrapyramidal or movement disorders (AAMR, 0.43; dYLL = −123,000), chronic lower respiratory diseases (AAMR, 0.65; dYLL, 
−379,000), other respiratory diseases principally affecting the interstitium (AAMR, 0.74; dYLL, −44,000), and other degenerative 
diseases of the nervous system (AAMR, 0.78; dYLL, −147,000), but these diseases generally contributed to small dYLLs.
Assault was the largest relative and absolute contributor to disparities between whites and Hispanics (AAMR, 2.64; dYLL, 1.2 million) 
(Figure, Panel B, and Supplemental Table 1). However, the Hispanic population had a substantially higher risk for death from only 2 
other causes: diseases of the liver (AAMR, 1.65; dYLL, 421,000) and diabetes (AAMR, 1.65; dYLL, 353,000). The Hispanic population 
had a lower risk than whites for death from malignant neoplasms (AAMR, 0.70; dYLL, −3.7 million) and ischemic heart disease 
(AAMR, 0.84; dYLL, −1.7 million), and both common diseases contributed to large dYLLs. Hispanics had substantially lower risk for 
death from intentional self-harm (AAMR, 0.47; dYLL, −1.5 million), chronic lower respiratory diseases (AAMR = 0.45; dYLL, −1.1 
million), other external causes of accidental injury (AAMR, 0.69; dYLL, −1.4 million), and other forms of heart diseases (AAMR, 0.59; 
dYLL, −814,000), and these substantially lower relative risks contributed to large dYLLs.
The AIAN population had a higher risk than the white population for death from several causes (Figure, Panel C, and Supplemental 
Table 1); however, the smaller size of the AIAN population contributed to modest dYLLs. Higher relative risks for death from assault 
th
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(AAMR, 3.25; dYLL, 98,000) and diseases of the liver (AAMR, 3.06; dYLL, 218,000) were striking, but they contributed to small 
dYLLs; differences in risk for death from diabetes (AAMR, 2.37; dYLL, 118,000) and transportation accidents (AAMR, 2.10; dYLL, 
248,000) also contributed to small dYLLs. Many other diseases posed a higher risk for the AIAN population than for whites, 
including other respiratory diseases principally affecting the interstitium (AAMR,1.64; dYLL, 14,000), renal failure (AAMR, 1.40; 
dYLL, 28,000), other bacterial diseases (AAMR, 1.31; dYLL, 28,000), influenza and pneumonia (AAMR, 1.24; dYLL, 34,000), ill-
defined or unknown causes of mortality (AAMR, 1.30; dYLL, 40,000), and other diseases of the intestine (AAMR, 1.15; dYLL, 8,000).
The AIAN population had a lower risk for death than the white population from several diseases, including other degenerative 
diseases of the nervous system (AAMR, 0.62; dYLL, −11,000), extrapyramidal and movement disorders (AAMR, 0.69; dYLL, 
−3,000), and organic mental disorders (AAMR, 0.71, dYLL, −7,000). In addition, the AIAN population had a lower relative risk for all 
5 leading causes of death: malignant neoplasms (AAMR, 0.80; dYLL, −158), ischemic heart diseases (AAMR = 0.84; dYLL, −12,000), 
other forms of heart disease (AAMR, 0.83; dYLL, 14,000), cerebrovascular disease (AAMR, 0.89; dYLL, 13K), and chronic lower 
respiratory diseases (AAMR, 0.82; dYLL, −14,000).
Finally, the API population had neither a higher relative risk nor a higher absolute risk than the white population for any cause of 
death, but it did have substantially fewer years of life lost and a lower risk for death from malignant neoplasms (AAMR, 0.60; dYLL, 
−2.0 million) and ischemic heart disease (AAMR, 0.57; dYLL, −1.4 million) (Figure, Panel D, and Supplemental Table 1).
The post hoc analysis of the 26th- to 50th-ranked causes of death (Supplemental scatterplots in Appendix and Supplemental Table 2) 
showed a pattern similar to that for the leading 25 causes of death. Numerous diseases contributed to disparities between whites and 
blacks and between whites and the AIAN population, whereas few diseases contributed to disparities between whites and Hispanics 
and between whites and the API population. Human immunodeficiency virus (HIV) was the 29th leading cause of death overall; for 
blacks, the AAMR was a remarkable 10.8 (dYLL, 2.9 million), placing HIV among the major contributors to disparities in mortality 
for blacks. HIV also played a substantial role in disparities for the Hispanic (AAMR, 2.80; dYLL, 449,000) and AIAN (AAMR, 1.60; 
dYLL, 12,000) populations. Childhood diseases were particularly noteworthy contributors to disparities between whites and blacks, 
especially disorders related to the length of gestation and fetal growth (AAMR, 3.79; dYLL, 1.3 million) and respiratory and 
cardiovascular disorders specific to the perinatal period (AAMR, 2.59; dYLL, 648,000). For Hispanics, only viral hepatitis (AAMR, 
3.65; dYLL, 124,000) was a striking contributor to disparities. For the AIAN population, substantial contributors to disparities were 
substance abuse (AAMR, 3.27; dYLL, 2,000), viral hepatitis (AAMR, 1.82; dYLL, 63,000) and systemic connective disease disorders 
(AAMR, 1.62; dYLL, 36,000). The dearth of diseases contributing to disparities between whites and the API population remained in 
the post hoc analysis.
Discussion
A few causes of death had a similar effect across racial/ethnic groups, whereas many others had different effects for different races or 
ethnicities. Assault played a major role in deaths among the black, Hispanic, and AIAN populations. Diabetes and diseases of the liver 
were the only other substantial contributors to relative or absolute disparities for the Hispanic population and were also the second- 
and third-largest contributors to disparities for the AIAN population. In contrast, the 4 leading causes of death (malignant 
neoplasms, ischemic heart disease, other forms of heart disease, and cerebrovascular disorders) placed blacks at higher risk than 
whites but placed all other racial/ethnic minority groups at lower risk. Hypertensive diseases, renal diseases, and other bacterial 
diseases increased disparities for the black population only. Hence, broad prevention strategies related to assault, diseases of the 
liver, and diabetes could reduce disparities in many racial/ethnic groups; our data suggest the need for targeting resources to certain 
combinations of causes of death that affect certain racial/ethnic populations more than others.
Compared with whites, the black and AIAN populations had a higher risk for death from numerous causes, while the Hispanic 
population had a higher risk from only 3 causes (assault, diseases of the liver, and diabetes), and the API population did not have a 
higher risk than whites from any cause. After assault, the largest dYLLs in any racial/ethnic group resulted from 3 diseases in the 
black population: malignant neoplasms, ischemic heart disease, and other forms of heart disease; each disease contributed to more 
than 2.0 million dYLLs. However, none of these 3 diseases contributed to disparities in the Hispanic or API population. Importantly, 
compared with the Hispanic population and the API population, the white population had a higher risk of death from cancer, 
ischemic heart disease, and other forms of heart disease. Cerebrovascular disease contributed to a substantial dYLL for the black 
population but had almost no effect on dYLLs for other racial/ethnic groups. These patterns are reflected in patterns of life 
expectancy (2), with shorter life expectancies for the black and AIAN populations and longer life expectancies for the Hispanic and 
API populations than for the white population.
Focusing on relative disparities shifts attention to several additional diseases: risk was more than double for the black population 
than for the white population for hypertensive diseases (AAMR, 2.99), renal failure (AAMR, 2.35) and other bacterial diseases 
(AAMR, 2.20); no other disease approached a doubling of risk for any racial/ethnic group.
If diseases related to vascular diseases and its risk factors were clustered (ischemic heart disease, other forms of heart disease, 
cerebrovascular diseases, diabetes, hypertension, and renal disease), they would contribute a remarkable 12.1 million in dYLL and 
dominate all other contributors to disparities between blacks and whites (and have little impact on other racial/ethnic groups).
With the goal of improving the health of people in all racial/ethnic groups in the United States, one could also attempt to find the 
largest disparities for whites by combining data for all other racial/ethnic groups. When we used this approach, we found that whites 
had 3.2 million in dYLL from intentional self-harm, 2.3 million in dYLL from other external causes of accidental injury, 2.1 million in 
dYLL from chronic lower respiratory diseases, 2.1 million in dYLL from cancers, and 1.2 million in dYLL from transportation 
accidents. There seems to be a promising opportunity to study these causes of death that lead to lower life expectancy among whites.
The objective of this paper was to identify the causes of death that contribute the most to relative and absolute measures of disparities 
in mortality among racial/ethnic groups and thereby provide a framework to guide investigators to efficiently investigate the 
contributors to (or mechanisms for) these disparities. These contributors and mechanisms will likely differ among causes and 
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racial/ethnic groups because of the heterogeneous mixture of individual characteristics (socioeconomic, psychosocial, genetic 
sources, and physiological) and societal exposures (availability of medical resources, neighborhood characteristics, environmental 
exposures, and others). Consider, for example, disparities in assault and diabetes. It seems likely that disparities in assault would be 
tightly tied to socioeconomic and psychosocial sources, whereas differences in diabetes would be driven more by physiological or 
genetic differences. However, by focusing on race–disease combinations that evidence the greatest disparities, further work can 
increase understanding of the contribution of specific diseases, and interventions can be developed to reduce these disparities. To 
make this task even more challenging, there are likely dynamic changes in the impact of diseases as contributors to disparities in 
mortality associated with shifts in deaths from certain diseases (1) and temporal changes in certain diseases that differ between men 
and women (6) and between regions of the country (7).
This study has several limitations. The estimates from the WONDER system rely on data from death certificates, introducing 2 
concerns. The first is misclassification of race/ethnicity: as noted by Arias and colleagues (8), the numerator of the death rate (the 
number of deaths) is based on the race/ethnicity indicated on the death certificate, information usually collected by physicians or 
funeral directors who gather the information from personal observation or from next of kin. The denominator of the death rate, the 
population size, is based on self-reported race/ethnicity from the US Census. That these data come from different sources introduces 
the possibility of differential reporting by racial/ethnic group and may affect the magnitude of disparity among racial/ethnic groups. 
Arias and colleagues concluded that this concern is minimal for data on whites and blacks and modest for Hispanic and API 
populations but may be substantial for AIAN populations. The second concern is the misclassification of cause of death. One study (9) 
examined data on underlying cause of death obtained from physician-adjudicated medical records (the gold standard) and compared 
these data with the underlying cause of death indicated on the death certificate. Considering cause of death on a broad basis, the 
study found that sensitivity ranged from 31% (death from infection) to 81% (death from cancer) and that the positive predictive value 
ranged from 31% (death from infection) to 50% (death from cancer); however, these gaps in the ability to identify diseases on death 
certificates would be smaller if a finer classification of causes of death existed (eg, an exact cause instead of a broad classification, 
such as cancer) Hence, misclassification could play a potentially different role across diseases.
Racial/ethnic differences in health exist in many domains that do not result in death and are not identified in these analyses. For 
example, mental health problems and diabetes have a profound impact on disparities in quality of life that are identified by measures 
such as the disability-adjusted life year (DALY) or quality-adjusted life year (QALY) but not by measures of mortality. However, it 
could be argued that events tied to death are the most serious and important and perhaps should be a primary guide to understanding 
disparities. In addition, several causes of death share risk factors and are correlated. A competing-cause analysis would partially 
address this question but is not feasible because of the number of causes of death that need to be considered.
In conclusion, although we found similarities in the contribution of causes of death to racial/ethnic disparities, we found larger 
differences. The importance of finding the contributors to disparities is growing, and without targeted studies the magnitude of 
disparities will move from bad to worse. For example, despite the remarkable and rapid 37% decline in stroke mortality (from 173.2 
per 100,000 in 1999 to 108.6 per 100,000 in 2009), the black–white stroke disparity increased by 25% (from a mortality ratio of 1.36 
in 1999 to 1.45 in 2009 [10]). Not only are there apparent increases in the geographic disparities in life expectancy (7) but disparities 
associated with socioeconomic status are likely growing; for example, wealthy counties have larger declines in cigarette smoking than 
poor counties (11). We hope that our data can be used as a road map to guide a call-to-action to aggressively target the contributors to 
racial/ethnic disparities and lead to interventions that will reduce them.
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Tables
Table 1. No. (%) of People Who Died of Any of the 25 Leading Causes of Death , by 
Racial/Ethnic Group , United States, 1999–2010
Category Total
Racial/Ethnic Group
Non-Hispanic 
White
Non-
Hispanic 
Black
Hispanic 
White
Non-Hispanic 
American Indian 
or Alaska Native
Non-Hispanic 
Asian or Pacific 
Islander
Person-years at risk 3,486,559,143 2,384,810,893 445,142,145 463,832,712 29,273,028 163,500,365
ICD-10 subchapter group
C00–C97: Malignant 
neoplasms
6,694,576 
(23)
5,484,107(23) 751,193 (22) 298,644 (20) 27,579 (18) 133,053 (27)
I20–I25: Ischemic heart 
diseases
5,400,064 
(19)
4,503,062 (19) 548,407 (16) 241,062 (16) 20,851 (13) 86,682 (17)
I30–I51: Other forms of 
heart disease
1,878,942 (6) 1,573,578 (7) 211,619 (6) 62,144 (4) 7,105 (5) 24,496 (5)
I60–I69: Cerebrovascular 
diseases
1,772,800 (6) 1,434,266 (6) 211,205 (6) 78,900 (5) 6,538 (4) 41,891 (8)
J40–J47: Chronic lower 
respiratory diseases
1,538,164 (5) 1,382,607 (6) 94,921 (3) 39,317 (3) 6,128 (4) 15,191 (3)
E10–E14: Diabetes 
mellitus
853,442 (3) 607,583 (3) 147,577 (4) 71,592 (5) 8,808 (6) 17,882 (4)
G30–G31: Other 
degenerative diseases of 
the nervous system
826,704 (3) 740,689 (3) 49,980 (1) 26,741 (2) 1,829 (1) 7,465 (2)
W00–X59: Other external 
causes of accidental injury
783,996 (3) 627,772 (3) 82,237 (2) 54,955 (4) 8,204 (5) 10,828 (2)
F01–F09: Organic, 
including symptomatic, 
mental disorders
759,587 (3) 667,749 (3) 58,872 (2) 22,367 (2) 1,833 (1) 8,766 (2)
J09–J18: Influenza and 
pneumonia
711,031 (2) 591,688 (3) 66,133 (2) 34,193 (2) 3,777 (2) 15,240 (3)
I10–I15: Hypertensive 
diseases
646,393 (2) 451,799 (2) 144,797 (4) 33,624 (2) 2,501 (2) 13,672 (3)
V01–V99: Transport 
accidents
536,681 (2) 384,677 (2) 65,348 (2) 65,716 (4) 9,482 (6) 11,458 (2)
N17–N19: Renal failure 493,520 (2) 365,965 (2) 90,113 (3) 26,050 (2) 2,909 (2) 8,483(2)
K70–K76: Diseases of liver 445,324 (2) 331,776 (1) 44,750 (1) 53,549 (4) 8,902 (6) 6,347 (1)
A30–A49: Other bacterial 
diseases
424,411 (1) 319,234 (1) 75,627 (2) 20,828 (1) 2,609 (2) 6,113 (1)
408,985 (1) 348,736 (1) 38,745 (1) 14,061 (1) 1,439 (1) 6,004 (1)
a
b
c
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Category Total
Racial/Ethnic Group
Non-Hispanic 
White
Non-
Hispanic 
Black
Hispanic 
White
Non-Hispanic 
American Indian 
or Alaska Native
Non-Hispanic 
Asian or Pacific 
Islander
I70–I78: Diseases of 
arteries, arterioles, and 
capillaries
X60–X84: Intentional self
–harm
393,603 (1) 331,714 (1) 23,433 (1) 25,101 (2) 4,219 (3) 9,136 (2)
K55–K63: Other diseases 
of intestines
251,124 (1) 211,341 (1) 24,955 (1) 10,538 (1) 1,321 (1) 2,969 (1)
J60–J70: Lung diseases 
due to external agents
214,234 (1) 185,016 (1) 18,528 (1) 6,919 (0) 851 (1) 2,920 (1)
G20–G25: Extrapyramidal 
and movement disorders
225,214 (1) 205,434 (1) 8,079 (0) 7,761 (1) 633 (0) 3,307 (1)
X85–Y09: Assault 204,201 (1) 64,483 (0) 96,072 (3) 36,787 (2) 2,654 (2) 4,205 (1)
J80–J84: Other respiratory 
diseases principally 
affecting the interstitium
199,234 (1) 166,500 (1) 14,049 (0) 13,247 (1) 1,524 (1) 3,914 (1)
E70–E88: Metabolic 
disorders
198,649 (1) 165,623 (1) 21,016 (1) 8,090 (1) 884 (1) 3,036 (1)
R95–R99: Ill–defined and 
unknown causes of 
mortality
197,958 (1) 143,082 (1) 34,611 (1) 15,639 (1) 1,923 (1) 2,703 (1)
N30–N39: Other diseases 
of urinary system
165,358 (1) 137,866 (1) 18,141 (1) 6,491 (0) 677 (0) 2,183 (0)
All other causes 2,840,148 
(10)
2,091,320 (9) 481,042 (14) 199,533 (14) 19,722 (13) 48,531 (10)
Abbreviations: ICD-10, International Classification of Diseases, 10th Revision.
 Source: Wide-Ranging Online Data for Epidemiologic Research (WONDER) system supported by the Centers for Disease Control and 
Prevention (4). Categories of causes of death established by the ICD-10.
 Because the number of deaths was too small to provide stable estimates, our racial/ethnic classification excluded a small number of 
Hispanic American Indians/Alaska Natives, Hispanic Asians/Pacific Islanders, and Hispanic blacks from the analyses (collectively 4,072,827 
of 3,530,708,204 [0.1%] of the total person-years at risk).
 Sum of the population in each of the 12 years of study.
Table 2. Age-Adjusted Mortality Rates for the 25 Leading Causes Of Death , by 
Racial/Ethnic Group , United States, 1999–2010
ICD-10 Subchapter Group
Age-Adjusted Mortality Rate
Non-
Hispanic 
White
Non-
Hispanic 
Black
Hispanic 
White
Non-Hispanic American 
Indian or Alaska Native
Non-Hispanic Asian 
or Pacific Islander
C00–C97: Malignant neoplasms 188.51 229.39 131.72 150.97 113.41
I20–I25: Ischemic heart diseases 151.27 179.46 127.12 127.30 86.67
I30–I51: Other forms of heart 
disease
52.77 67.22 31.27 43.67 24.70
I60–I69: Cerebrovascular diseases 47.96 69.28 40.28 42.61 41.54
J40–J47: Chronic lower respiratory 
diseases
46.89 30.70 21.32 38.37 15.87
E10–E14: Diabetes mellitus 20.78 46.38 34.19 49.19 16.95
G30–G31: Other degenerative 
diseases of the nervous system
24.30 18.93 16.80 15.00 8.79
W00–X59: Other external causes of 
accidental injury
23.66 21.35 16.25 33.81 9.02
F01–F09: Organic, including 
symptomatic, mental disorders
21.77 22.27 14.26 15.41 10.55
a
b
c
a
b
c
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ICD-10 Subchapter Group
Age-Adjusted Mortality Rate
Non-
Hispanic 
White
Non-
Hispanic 
Black
Hispanic 
White
Non-Hispanic American 
Indian or Alaska Native
Non-Hispanic Asian 
or Pacific Islander
J09–J18: Influenza and pneumonia 19.75 22.06 18.13 24.53 16.59
I10–I15: Hypertensive diseases 15.15 45.27 16.76 14.92 13.95
V01–V99: Transport accidents 15.74 15.10 14.81 32.99 7.46
N17–N19: Renal failure 12.32 28.99 12.84 17.28 8.40
K70–K76: Diseases of liver 11.81 11.73 19.45 36.09 4.96
A30–A49: Other bacterial diseases 10.90 24.03 9.58 14.30 5.79
I70–I78: Diseases of arteries, 
arterioles and capillaries
11.71 12.88 7.36 9.36 5.98
X60–X84: Intentional self–harm 13.22 5.39 6.06 14.15 5.68
K55–K63: Other diseases of 
intestines
7.12 8.16 5.37 8.19 3.00
G20–G25: Extrapyramidal and 
movement disorders
6.89 2.93 4.56 4.77 3.61
J60–J70: Lung diseases due to 
external agents
6.16 6.45 3.90 5.89 3.29
X85–Y09: Assault 2.73 20.63 7.22 8.87 2.47
R95–R99: Ill–defined and unknown 
causes of mortality
5.55 8.35 3.87 7.20 1.92
J80–J84: Other respiratory diseases 
principally affecting the interstitium
5.68 4.21 6.46 9.25 3.77
E70–E88: Metabolic disorders 5.70 6.79 3.66 5.04 2.90
N30–N39: Other diseases of urinary 
system
4.57 6.48 3.70 4.79 2.39
Abbreviations: ICD-10, International Classification of Diseases, 10th Revision.
 Source: Wide-Ranging Online Data for Epidemiologic Research (WONDER) system supported by the Centers for Disease Control and 
Prevention (4). Categories of causes of death established by the ICD-10.
 Because the number of deaths was too small to provide stable estimates, our racial/ethnic classification excluded a small number of 
Hispanic American Indians/Alaska Natives, Hispanic Asians/Pacific Islanders, and Hispanic blacks from the analyses (collectively 4,072,827 
of 3,530,708,204 [0.1%] of the total person-years at risk).
 Ranked in decreasing order by death rate for the non–Hispanic white population.
Appendix. Supplemental Tables and Figures
Supplemental Table 1. Data for Figure on Age-Adjusted Mortality Ratio (AAMR) 
and Difference in Years of Life Lost (dYLL), by Racial/Ethnic Group  for the 25 
Leading Causes of Death as Classified by the ICD-10, United States, 1999–2010
ICD-10 Subchapter Group
Non-Hispanic 
Black Hispanic White
Non-Hispanic American 
Indian or Alaskan Native
Non-Hispanic Asian or 
Pacific Islander
AAMR dYLL AAMR dYLL AAMR dYLL AAMR dYLL
C00–C97: Malignant neoplasms 1.22 3,781,343 0.70 −3,724,049 0.80 −158,197 0.60 −1,979,722
I20–I25: Ischemic heart 
diseases
1.19 2,725,283 0.84 −1,728,080 0.84 −11,696 0.57 −1,368,421
I30–I51: Other forms of heart 
disease 
1.27 2,052,395 0.59 −814,436 0.83 14,032 0.47 −500,768
I60–I69: Cerebrovascular 
diseases
1.44 2,000,212 0.84 −83,787 0.89 12,653 0.87 −30,913
J40–J47: Chronic lower 
respiratory diseases
0.65 −379,109 0.45 −1,091,025 0.82 −14,047 0.34 −624,294
E10–E14: Diabetes mellitus 2.23 1,804,677 1.65 352,592 2.37 117,812 0.82 −178,102
G30–G31: Other degenerative 
diseases of the nervous system
0.78 −147,356 0.69 −172,533 0.62 −11,371 0.36 −154,368
c
a
b
c
a
b
a
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ICD-10 Subchapter Group
Non-Hispanic 
Black Hispanic White
Non-Hispanic American 
Indian or Alaskan Native
Non-Hispanic Asian or 
Pacific Islander
AAMR dYLL AAMR dYLL AAMR dYLL AAMR dYLL
W00–X59: Other external 
causes of accidental injury
0.90 −84,254 0.69 −1,389,452 1.43 128,626 0.38 −917,067
F01–F09: Organic, including 
symptomatic, mental disorders
1.02 56,571 0.66 −146,607 0.71 −7,328 0.48 −107,692
J09–J18: Influenza and 
pneumonia
1.12 415,726 0.92 −78,038 1.24 33,886 0.84 −94,824
I10–I15: Hypertensive diseases 2.99 2,349,699 1.11 25,013 0.98 9,194 0.92 −72,527
V01–V99: Transport accidents 0.96 −190,089 0.94 −548,674 2.10 248,013 0.47 −724,126
N17–N19: Renal failure 2.35 1,228,893 1.04 47,097 1.40 28,364 0.68 −73,046
K70–K76: Diseases of liver 0.99 90,599 1.65 421,214 3.06 218,017 0.42 −330,094
A30–A49: Other bacterial 
diseases
2.20 977,585 0.88 −82,001 1.31 27,764 0.53 −122,342
I70–I78: Diseases of arteries, 
arterioles and capillaries
1.10 182,329 0.63 −160,671 0.80 −3,370 0.51 −94,127
X60–X84: Intentional self–harm 0.41 −1,242,755 0.46 −1,494,701 1.07 58,100 0.43 −543,803
K55–K63: Other diseases of 
intestines
1.15 169,834 0.75 −72,454 1.15 8,210 0.42 −75,055
G20–G25: Extrapyramidal and 
movement disorders
0.43 −123,259 0.66 −64,464 0.69 −2,955 0.52 −40,962
J60–J70: Lung diseases due to 
external agents
1.05 51,176 0.63 −82,442 0.96 1,532 0.53 −52,448
X85–Y09: Assault 7.56 4,506,949 2.64 1,249,884 3.25 97,797 0.90 −25,887
R95–R99: Ill–defined and 
unknown causes of mortality
1.50 787,630 0.70 −405,927 1.30 40,471 0.35 −214,763
J80–J84: Other respiratory 
diseases principally affecting 
the interstitium
0.74 −43,617 1.14 9,302 1.63 13,704 0.66 −47,064
E70–E88: Metabolic disorders 1.19 44,249 0.64 −180,021 0.88 −814 0.51 −81,486
N30–N39: Other diseases of 
urinary system
1.42 96,243 0.81 −24,589 1.05 2,703 0.52 −29,071
Abbreviations: ICD-10, International Classification of Diseases, 10th Revision.
 Because the number of deaths was too small to provide stable estimates, our racial/ethnic classification excluded a small number of 
Hispanic American Indians/Alaska Natives, Hispanic Asians/Pacific Islanders, and Hispanic blacks from the analyses (collectively 4,072,827 
of 3,530,708,204 [0.1%] of the total person-years at risk).
 Each group was compared with non-Hispanic whites.
a
a
b
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Supplemental Figure. Scatterplots of relative disparities (age-adjusted mortality ratio) and absolute disparities (years of life lost) for 
each of 4 racial/ethnic minority groups compared with the non-Hispanic white population for the 26th- to 50 -ranked leading causes 
of death in the United States, 1999–2010. Causes of death were categorized according to the International Classification of 
Diseases, 10  Revision. Scatterplot A is for non-Hispanic blacks; B is for Hispanic whites; C is for non-Hispanic Asians/Pacific 
Islanders; and D is for non-Hispanic American Indians/Alaska Natives. Abbreviations for categories of causes of death were used to 
provide clearer plots. Abbreviations: PHD, pulmonary heart disease and diseases of pulmonary circulation; General, general 
symptoms and signs; Unk Neoplasms, neoplasms of uncertain or unknown behavior; HIV, human immunodeficiency virus disease; 
Substance Use, mental or behavioral disorders due to psychoactive substance use; Gal BilTract Pan, disorders of gallbladder, biliary 
tract, or pancreas; Other Digest, other diseases of the digestive system; Other Respiratory, other diseases of the respiratory system; 
Other Nervous, other disorders of the nervous system; Sys Atrophies, systemic atrophies primarily affecting the central nervous 
system; Esophagus stomach duod, diseases of esophagus, stomach, or duodenum; Hepatitis, viral hepatitis; Intestinal Infect, 
intestinal infectious diseases; Undetermined Intent, event of undetermined intent; Fetal Growth, disorders related to length of 
gestation or fetal growth; Connective Tissue, systemic connective tissue disorders; Obesity, obesity or other hyperalimentation; 
Arthropathies, arthropathies; Veins Lymphatic, diseases of veins, lymphatic vessels, or lymph nodes, not elsewhere classified; 
Circulatory Malform, congenital malformations of the circulatory system.
Supplemental Table 2. Data for Supplemental Figure on Age-Adjusted Mortality 
Ratio (AAMR) and Difference in Years of Life Lost (dYLL), Plus Age-Adjusted 
Mortality Rates, by Racial/Ethnic Group , for the 26th- to 50th-Ranked Causes of 
Death as Classified by the ICD-10, United States, 1999–2010
ICD-10 
Subchapter 
Group
Non-
Hispanic 
White Non-Hispanic Black Hispanic White
Non-Hispanic 
American Indian or 
Alaskan Native
Non-Hispanic Asian or 
Pacific Islander
Rate AAMR Rate dYLL AAMR Rate dYLL AAMR Rate dYLL AAMR Rate dYLL
A00-A09: 
Intestinal 
infectious 
diseases
1.81 1.34 0.74 14,275 1.40 0.77 −1,722 1.64 0.91 1,569 0.72 0.40 −15,603
th
th
a
b
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ICD-10 
Subchapter 
Group
Non-
Hispanic 
White Non-Hispanic Black Hispanic White
Non-Hispanic 
American Indian or 
Alaskan Native
Non-Hispanic Asian or 
Pacific Islander
Rate AAMR Rate dYLL AAMR Rate dYLL AAMR Rate dYLL AAMR Rate dYLL
B15-B19: Viral 
hepatitis
1.77 2.85 1.61 118,894 3.65 2.07 139,425 3.21 1.82 13,044 2.37 1.34 −7,360
B20-B24: Human 
immunodeficiency 
virus [HIV] 
disease
1.80 19.43 10.81 2,957,106 5.04 2.80 475,611 2.88 1.60 12,361 0.57 0.32 −86,854
D37-D48: 
Neoplasms of 
uncertain or 
unknown behavior
4.36 3.61 0.83 −2,217 2.92 0.67 −54,049 3.29 0.75 −3,251 2.37 0.54 −43,205
D60-D64: Aplastic 
and other 
anemias
1.12 1.81 1.61 51,909 0.94 0.84 1,019 1.21 1.08 1,030 0.73 0.65 −4,250
E65-E68: Obesity 
and other 
hyperalimentation
1.36 2.43 1.78 162,285 0.91 0.67 −44,564 1.85 1.36 5,779 0.22 0.16 −55,233
F10-F19: Mental 
and behavioral 
disorders due to 
psychoactive 
substance use
3.03 4.49 1.48 182,083 2.87 0.95 −18,684 9.88 3.27 66,826 0.57 0.19 −140,138
G10-G12: 
Systemic 
atrophies 
primarily affecting 
the central 
nervous system
2.61 1.30 0.50 −95,134 1.30 0.50 −101,981 1.20 0.46 −8,240 0.92 0.35 −59,034
G35-G37: 
Demyelinating 
diseases of the 
central nervous 
system
1.26 1.16 0.93 17,085 0.34 0.27 −69,460 0.40 0.32 −5,135 0.12 0.09 −45,209
G90-G98: Other 
disorders of the 
nervous system
2.42 5.19 2.15 285,330 2.04 0.84 −42,216 2.93 1.21 4,760 1.54 0.64 −39,268
I05-I09: Chronic 
rheumatic heart 
diseases
1.14 0.88 0.77 17,729 0.86 0.75 −2,497 1.12 0.98 1,644 0.88 0.77 −160
I26-I28: 
Pulmonary heart 
disease and 
diseases of 
pulmonary 
circulation
4.32 7.68 1.78 364,562 2.30 0.53 −117,555 3.39 0.78 −617 1.46 0.34 −82,762
I80-I89: Diseases 
of veins, 
lymphatic vessels 
and lymph nodes, 
not elsewhere 
classified
1.22 2.28 1.87 127,804 1.02 0.83 −18,277 1.06 0.87 −104 0.39 0.32 −27,836
J96-J98: Other 
diseases of the 
respiratory 
system
2.67 3.56 1.33 128,686 1.44 0.54 −47,483 2.64 0.99 1,280 1.20 0.45 −32,465
K20-K31: 
Diseases of 
esophagus, 
stomach and 
duodenum
2.25 2.23 0.99 39,723 1.63 0.73 −26,776 2.36 1.05 1,944 1.62 0.72 −20,335
K80-K86: 
Disorders of 
2.59 3.38 1.31 111,881 2.86 1.11 4,194 3.80 1.47 6,930 1.99 0.77 −25,654
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ICD-10 
Subchapter 
Group
Non-
Hispanic 
White Non-Hispanic Black Hispanic White
Non-Hispanic 
American Indian or 
Alaskan Native
Non-Hispanic Asian or 
Pacific Islander
Rate AAMR Rate dYLL AAMR Rate dYLL AAMR Rate dYLL AAMR Rate dYLL
gallbladder, biliary 
tract and 
pancreas
K90-K92: Other 
diseases of the 
digestive system
2.67 3.42 1.28 74,729 1.51 0.57 −34,489 3.00 1.12 3,574 1.29 0.48 −26,618
M00-M25: 
Arthropathies
1.44 1.22 0.85 1,440 1.11 0.77 −5,434 2.19 1.52 3,802 0.71 0.50 −12,552
M30-M35: 
Systemic 
connective tissue 
disorders
1.21 2.78 2.29 295,692 1.52 1.26 63,508 1.96 1.62 7,132 0.91 0.75 1,982
M80-M94: 
Osteopathies and 
chondropathies
1.07 1.07 1.00 15,003 0.67 0.63 −6,579 1.19 1.11 994 0.51 0.47 −8,388
P05-P08: 
Disorders related 
to length of 
gestation and 
fetal growth
1.12 4.24 3.79 1,265,783 1.26 1.13 82,276 1.26 1.13 3,970 0.96 0.86 −20,805
P20-P29: 
Respiratory and 
cardiovascular 
disorders specific 
to the perinatal 
period
0.99 2.59 2.61 648,133 1.06 1.07 37,762 0.85 0.86 −3,830 0.74 0.75 −32,546
Q20-Q28: 
Congenital 
malformations of 
the circulatory 
system
1.27 1.63 1.28 138,912 1.20 0.94 10,650 1.34 1.06 4,250 0.88 0.69 −32,939
R50-R68: General 
symptoms and 
signs
4.31 5.26 1.22 147,760 2.35 0.55 −53,582 3.31 0.77 1,717 1.68 0.39 −44,484
Y10-Y34: Event of 
undetermined 
intent
1.78 1.86 1.04 2,761 0.82 0.46 −209,729 2.72 1.52 12,466 0.49 0.27 −107,190
Abbreviations: ICD-10, International Classification of Diseases, 10th Revision.
 Because the number of deaths was too small to provide stable estimates, our racial/ethnic classification excluded a small number of 
Hispanic American Indians/Alaska Natives, Hispanic Asians/Pacific Islanders, and Hispanic blacks from the analyses (collectively 4,072,827 
of 3,530,708,204 [0.1%] of the total person-years at risk).
 Each group was compared with non-Hispanic whites.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health 
and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions.
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b
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